Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Prepaid Assets (2018 - 2025)

Quantum Biopharma's Prepaid Assets history spans 8 years, with the latest figure at $15290.0 for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 77.85% to $15290.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $15290.0, a 77.85% decrease, with the full-year FY2025 number at $15290.0, down 77.85% from a year prior.
  • Prepaid Assets hit $15290.0 in Q4 2025 for Quantum Biopharma, down from $69036.0 in the prior quarter.
  • Over the last five years, Prepaid Assets for QNTM hit a ceiling of $1.4 million in Q4 2021 and a floor of $15290.0 in Q4 2025.
  • Historically, Prepaid Assets has averaged $415659.4 across 5 years, with a median of $155413.0 in 2023.
  • Biggest five-year swings in Prepaid Assets: surged 139.98% in 2021 and later crashed 77.85% in 2025.
  • Tracing QNTM's Prepaid Assets over 5 years: stood at $1.4 million in 2021, then tumbled by 65.45% to $472137.0 in 2022, then plummeted by 67.08% to $155413.0 in 2023, then crashed by 55.58% to $69036.0 in 2024, then crashed by 77.85% to $15290.0 in 2025.
  • Business Quant data shows Prepaid Assets for QNTM at $15290.0 in Q4 2025, $69036.0 in Q4 2024, and $155413.0 in Q4 2023.